Vivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearance
November 29, 2023 at 11:09 AM EST
Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|